Key Findings:  Current evidence is weak for the recommended use of cannabinoids in the treatment of urinary disorders such as neurogenic bladder dysfunction (clinical studies), renal disease (animal studies), and interstitial cystitis (animal studies). Further, high-quality research is recommended.
Type of Study:  Meta-analysis
Study Sample Size:  62
Study Result:  Inconclusive
Research Location(s):  United Kingdom
Year of Pub:  2021
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Citation:  Taylor C and Birch B. Cannabinoids in Urology. Which Benign Conditions Might They Be Appropriate to Treat: A Systematic Review. Urology. 2021; 148:8-25. doi: 10.1016/j.urology.2020.10.024
Authors:  Taylor C, Birch B